Surgery Partners, Inc. reaffirms its 2022 Adjusted EBITDA guidance of $375 million to $385 million and its 2022 Revenue guidance of $2.50 billion to $2.55 billion based on results through November 2022.
AI Assistant
SURGERY PARTNERS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.